Milestone Pharmaceuticals Inc

MISTNASDAQ · USD
0.92USD0.00 (-0.42%)
122

Milestone Pharmaceuticals Inc (MIST) Implied Volatility Current

MIST implied volatility is 365%. IV Rank is 98%, placing current premiums in the top of their 52-week range.

Read more

Tracking MIST implied volatility helps you identify when options premiums on Milestone Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Milestone Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when MIST IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Milestone Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For MIST, tracking metrics like MIST IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on MIST signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where MIST implied volatility sits today versus where it has been. Our scanner ranks Milestone Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in MIST IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Milestone Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
98.02%IV Rank
High

IV is near its yearly peak - premiums are expensive, favoring sellers.

Implied Volatility (30d)364.86%

IV Rank98.02%

Historical Volatility (30d)67.93%

IV - HV+296.93%

As of September 18, 2026

Trade options with IV on your side

Track MIST IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial